C-UZXSYuva Biosciences
AI platform, mitochondrial science, compound discovery
discoverydiscoveringsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-UZXS
C-UZXSC-UZXSAI platform, mitochondrial science, compound discovery
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Advisory Board – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Advisory Board Philip A. Shearer Julie Kenner, MD Andrew Romans. Dr. Nabil Sakkab Jeffrey D. Weedman Matt Kaeberlein, PhD Frank L. Jaksch, Jr Robert K.Naviaux, MD, PhD Steve Yoelin, MD Home About Us News Careers Contact Home About Us News Careers Contact Company HQ/Lab:1500 First Avenue N, Suite L133, Birmingham, A
MitoNova AI – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Technology Platform MitoNova AI An AI system designed to predict biologically active compounds that modulate mitochondrial health, with an embedded validation layer ensuring all computational insights are tested on YuvaBio-designed assay systems. Yuva Biosciences has developed the first AI discovery platform for mitoc
Careers – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Careers Openings Positions listed below may be available at Yuva Biosciences’ Birmingham location near UAB. Candidates at the Principal Research Scientist and Research Scientist level are expected to be self-motivated, resourceful and should hold an MD or PhD degree. Those with experience in drug screening, assay developm … dling, breeding, mitochondrial biology, and genetics are strongly encouraged to apply. Research Scientist, Assay Development Associate Research Scientist/Operations Manager To apply please submit your resume using the form on the Contact Us Page. Home About Us News Careers Contact Home About Us News Careers Contact Company HQ/Lab:1500 First Avenue N, Suite L133, Birmingham, AL 35203 +New York City and Boston Copyright © 2026 All rights reserved. Developed by Aziz Bhatti
Speakers | Aesthetics Innovation Summit | May 13th, 2026 | Boston, MA About Agenda Program Speakers Attendees Presenting Companies Sponsors Current Sponsors Sponsorship Opportunities Floorplan Get Involved Travel Register Warning! Web API Url is not set for the Speaker Bios. Speaker Biographies Filter by: Last Name Organization Program Clear Filters ‹ › × Bill Andriopoulos, PhD, Global Head of Medical Affairs, Galderma Global Head of Medical Affairs Galderma Bill Andriopoulos, PhD currently serves as Vice President and Head of Medical Affairs for Galderma US, a role he has he … icine and BSc in Physiology from McGill University. He completed a postdoctoral fellowship at Harvard Medical School’s Massachusetts General Hospital, where he was first author on a Nature publication and received the 2008 HMS-MGH Award for Medical Excellence in Research. He has published extensively in the fields of aesthetics—including biostimulators, neuromodulators, dermal fillers, and safety—as well as in iron metabolism. Aesthetics Innovation Summit Andy Balk, PhD … , will be the recipient of The Aesthetic Foundation’s 2024 Career Achievement Award. The presentation will take place on Saturday, May 4 during The Aesthetic Meeting 2024 in Vancouver. Dr. Casas, the first woman to serve as Foundation President (2009-2010), will also be the first woman to receive this prestigious honor in recognition of her significant contributions to the aesthetic plastic surgery specialty. Highlights of her accomplished resume include: • Completed 3 Fe … omplished resume include: • Completed 3 Fellowships following Plastic Surgery Residency at Northwestern University Medical School: • 1988 Clinicel Fellow Microsurgery and Research Fellow, Southern Illinois University, Springfield, IL • 1989 Clinical Aesthetic Plastic Surgery Fellow, New York University/Manhattan Eye, Ear and Throat (MEETH), New York City • 1989 Clinical Aesthetic Breast Reconstruction Fellow St. Joseph Hospital – Emory University, Atlanta, GA • 19 … ated physician, Johns Hopkins–trained plastic and reconstructive surgeon, and fellowship-trained aesthetic surgeon. He is the founder of Mirror Plastic Surgery in St. Petersburg, Florida, a boutique concierge practice offering head-to-toe plastic surgery, injectables, and comprehensive wellness care including peptides and sexual health. He also
Careers – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Careers Openings Positions listed below may be available at Yuva Biosciences’ Birmingham location near UAB. Candidates at the Principal Research Scientist and Research Scientist level are expected to be self-motivated, resourceful and should hold an MD or PhD degree. Those with experience in drug screening, assay developm … dling, breeding, mitochondrial biology, and genetics are strongly encouraged to apply. Research Scientist, Assay Development Associate Research Scientist/Operations Manager To apply please submit your resume using the form on the Contact Us Page. Home About Us News Careers Contact Home About Us News Careers Contact Company HQ/Lab:1500 First Avenue N, Suite L133, Birmingham, AL 35203 +New York City and Boston Copyright © 2026 All rights reserved. Developed by Aziz Bhatti
Stock Quotes - Welcome, guest! - Log on | Join ($$) VF "How To" Guide Welcome, guest ! Learn about guest access The Coffee Shop BDC Investor Canada Stock Channel CDx3 Investor CEF Channel ChartZero Contrarian Outlook Dividend Channel Energy Stock Channel ETF Channel Holdings Channel Market News Video Metals Channel Portfolio Channel Preferred Stock Channel Stock Options Channel The Online Inve
Matt Kaeberlein - Optispan, Inc. | Global Longevity Summit Speaker You need to enable JavaScript to run this app. This site is part of the Informa Connect Division of Informa PLC Informa PLC About Us Investor relations Talent This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067. 28-30 October 2025 Genolier Innovation Hub Geneva, Switzerland Home home Agenda Speakers Delegates Sponsorship Prospectus Plan Your Visit Contac
EX-99.1 3 ea023722401ex99-1_pmgchold.htm PRESS RELEASE DATED APRIL 10, 2025 Exhibit 99.1 Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases ● Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel pharmaceutical treatments for obesity, type 2 diabetes and other cardiometabolic conditions. ● Northstrive and Yuva Bios … putational findings for biological activity on custom assays. YuvaBio will also grant Northstrive an exclusive, worldwide license to this developed technology to derive therapeutic products for cardiac diseases and obesity. Through this collaboration, the parties aim to integrate new methodologies into mitochondrial biology and discover outputs to expand Northstrive’s cardiometabolic disease pipeline. The AI Development Program will combine YuvaBio’s propri
User | thepilotnews.com - Latest News about PMGC Holdings Inc. - Common Stock (Nasdaq:ELAB) | PMGC Holdings Inc. - Common Stock (Nasdaq:ELAB) News Skip to main content Contact Us Subscribe Promote Your Event e-Edition Privacy Policy Terms of Service Local Weather Home Delivery Submission Forms News Local News The Leader Sports Obituaries Classifieds Real Estate Property for Rent Cars & Vehicles Jobs Items for Sale Pets Auctions, Estate & Garage Sales Services Community Personals Place an ad Legals Archives Best of 2026 Pilot News E-Edition Culver Citizen Contact Us Subscribe e-Edition Sign Up
Yuva Biosciences, Inc. - Phone, Email, Employees, CEO, VP, 2024 Our Platform Powerful Sales Intelligence Platform Overview Buyer Intent Data B2B Prospect Data Website Visitor ID Email Tracking Why? Your Challenges Our Data See For Yourself Pricing Resources Resellers Add Ons Call Tracking Keyword Level Tracking Reputation Management Integrations About Us Contact Atlanta Jacksonville Blog Careers Support 888-586-7730 --> Login Free Trial Schedule A Demo × Our Platform Platform Overview Buyer Intent Data B2B Prospect Data Website Visitor Id Email Tracking Why? Your Challenges Our Data See
IMCAS - Congresses on Dermatology and Aesthetic & Plastic Surgery Academy Webinars Library Insider magazine Podcasts Report Sponsor Academy Academy Webinars Library Insider magazine Podcasts Report Sponsor Access is restricted to physicians To watch this video, please sign in Sign in Do not have an account yet? Create your IMCAS account Go back Innovation Tank 2025 Start-up competitor: Yuva Biosciences - YuvaBio Y100 Share Saksham NARANG Industry representative United States Disclosures - Saksham NARANG > Did you receive any funding to support your research for this TOPIC? No > Were you pr … 27 IMCAS Americas 2027 About The IMCAS story Scientific Partners Feedback IMCAS Fund Discover IMCAS Academy Webinars Library Insider magazine Podcasts Follow IMCAS Need assistance? Contact us Read FAQs Privacy policy Legal information © 2026 IMCAS International Master Course on Aging Science. All rights reserved. Accessibility : non-compliant Congresses IMCAS Asia 2026 IMCAS China 2026 IMCAS World 2027 IMCAS Americas 2027 Discover IMCAS Academy Webinars Library Insider magazi … ider magazine Podcasts About The IMCAS story Scientific Partners Feedback IMCAS Fund Need assistance? Contact us Read FAQs Privacy policy Legal information Follow IMCAS © 2026 IMCAS International Master Course on Aging Science. All rights reserved. Accessibility : non-compliant Processing, please wait... Error Please fill out all required fields. Here are the fields that are missing: OK IMCAS Search... Open menu Congresses IMCAS Asia 2026 19 - 21 June 2026 BANGKOK & ONLIN … us FAQ View our most Frequently Asked Questions Contact How can we help? IMCAS Fund Membership Sign in en IMCAS Close menu Congresses Academy Community About Membership IMCAS Asia 2026 19 - 21 June 2026, BANGKOK & ONLINE IMCAS China 2026 27 - 29 August 2026, SHANGHAI IMCAS World 2027 28 - 30 January 2027, PARIS & ONLINE IMCAS Americas 2027 20 - 22 May 2027, SãO PAULO INVEST by IMCAS 2027 January 27th, 2027, PARIS Webinars Live and on-demand access to the latest in aesthetic
%PDF-1.3 %��������� 4 0 obj > stream x�Zג��}�W\�*c�4 ���U�`�=k�k����! !P�� ������"���j���v8 �O�'�I��p=�\{���gU�٫�Uq�\��c̠Ѽ����\e�:��x���q�v m7w�� �>=���2�َ�p����%-��I��!D^�J� ���^�\/t�~�0�x��7p �����yN'~� ��U�B-�PŹzy���W~�s5��'f�?Z�Q�7u]�i�h�]먺Q�J�q��ǩ.��n�L�}���IˢV?FE�ՕR7����� ��}��rNFn1�D���\&[�L0?B��4+���� ���#Pq�r�P�/Ӳ&�c]�z�/bG�XfNZ#�� �b;tD��?�zG����3�� 6�6+G==��� 0?��-���_!��$��� �]��C�/7�UQqTp �7��w��.��� _���L�5��Ʌ��"�ׅ��2~�ȇ�mԨ��r(j����x����Q���������#�~Jۭ�GiRR�Mzm�ޚN�c���$��o� �ix6�Jr$���LDѝ��.�0M� ��O�l�M�?��Կ�H�n'� �9�tU�K�ՠ�qY�:ֈ���\X� Ԝ
#longevity #healthspan #mitochondria #agingscience #mitochondrialmedicine #longevityconference | Acasta Health Pvt Ltd LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or
BIO Alabama - Yuva Biosciences, Inc. is seeking an exceptional drug discovery scientist Menu Log in Home 2026 Annual Conference Investor Opportunities Tapping Into Bioscience Talent Pool AIDT Events BIO Alabama Brief Job Board About Board of Directors About Alabama's Biotech Industry Membership Join BIO Alabama BIO Business Solutions News Ecosystem Contact Log in with Facebook --> Log in with Google Log in with Microsoft Log in with Apple Remember me Forgot password Home 2026 Annual Conference Investor Opportunities Tapping Into Bioscience Talent Pool AIDT Events BIO Alabama Brief Job Boar … and effectively document and communicate results Has a demonstrated ability to apply a variety of state-of-the-art biochemical and genetic methods related to cell proliferation, apoptosis, cytotoxicity, and molecular pathways related to therapeutic agents. Has solid hands-on experience in handling mice and basic cell culture / genetic manipulation techniques as well as molecular and cell biology approaches. Strong working knowledge of computer software including Excel and Po … ublished by Elsevier. Yuva Biosciences is headquartered in Birmingham, Alabama. Apply online at http://yuvabio.com/careers.php Tweet Connecting the Bioscience Ecosystem in Alabama BIO Alabama P.O. Box 583 Arab, AL 35016 [email protected] © BIO Alabama Powered by Wild Apricot Membership Software
--> Yuva Bio secures $7.5M for topical skin and hair treatment targeting mitochondrial dysfunction Medical Technology 3D Printing AI in Healthcare Assistive Technology Digital Health Digital Modeling Laboratory Automation Nanotechnology in Healthcare Precision Medicine Robotic Surgery Synthetic Biology Health Antibiotic Resistance Big Pharma Cancer Diabetes Heart Disease Mental Health Musculoskeletal System Respiratory Disease Stroke Augmentation Artificial Organs Biohacking Brain Interface Exoskeleton Nootropics Prostheses Vision Life Extension Aging Research Anti-Aging Biological Age Calorie
Greg Schmergel - Co-Founder and CEO at Yuva Biosciences, Inc. | The Org Platform Enrich Pricing Log in Sign up Yuva Biosciences, Inc. Greg Schmergel Unverified GS Greg Schmergel Co-Founder and CEO Contact Greg Schmergel has a diverse work experience spanning several industries and roles. Greg is currently the Co-Founder and CEO of Yuva Biosciences, Inc., a position they have held since September 2021. Prior to this, they served as the Executive Chairman of the same company from April 2019 to August 2021. In addition, Schmergel has held various leadership positions in other organizations. Gre
Intersection of Regenerative Medicine & Healthspan - World Stem Cell Summit About WSCS About Us 2026 Regenerative Medicine Essentials Course Past WSCS Speakers WSCS Public Day (2023) Effective Patient Advocacy Symposium Intersection of RegMed & Healthspan Regenerative Medicine & the Commercial Space Economy Hot Topics in 2023 at World Stem Cell Summit Partners/Sponsors Partners/Sponsors Sponsorship Opportunities Upcoming Events News & Media News and Opinions WSCS 2023 Photos WSCS Video Contact Us Select Page Slide SPECIAL SYMPOSIUM & FOCUS SESSIONS Intersection of Regene
Instagram Instagram Log In Sign Up Close Never miss a post from bhmbizalliance Sign up for Instagram to stay in the loop. Sign up Log in bhmbizalliance • Follow More options bhmbizalliance 71w Do you work in bioscience? If so, this one's for you! 🧬 On Thursday, March 20 from 8:30 to 10:30 a.m. at @InnovationDepot , join us for our first Beakers & Brews of the year! Unlike previous Beakers & Brews, this one will be a coffee hour, where you can fuel up on brews provided by @calacoffeeco . ☕️ While you sip on your morning brew, hear from Yuva Biosciences Vice President Saksham Naran
Keshav K. Singh, PhD - World Stem Cell Summit About WSCS About Us 2026 Regenerative Medicine Essentials Course Past WSCS Speakers WSCS Public Day (2023) Effective Patient Advocacy Symposium Intersection of RegMed & Healthspan Regenerative Medicine & the Commercial Space Economy Hot Topics in 2023 at World Stem Cell Summit Partners/Sponsors Partners/Sponsors Sponsorship Opportunities Upcoming Events News & Media News and Opinions WSCS 2023 Photos WSCS Video Contact Us Select Page Keshav K. Singh, PhD Keshav K Singh, PhD Founder of Mitochondria Research and Medicine Society, Found
PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024 - PMGC PMGC holdings Home Investors Back SEC Filings Governance Corporate Directory Downloads News Back News 2026 News 2025 News 2024 News 2023 News 2022 News 2021 Our History subpages banner 456 We rely on the capital markets for the growth of our brands. PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024 Deploys Capital into Cash-Flowing Manufacturing Bus … he FDA has provided a clear path forward for filing an Investigational New Drug application to conduct a Phase 2 trial evaluating EL-22 in combination with GLP-1 receptor agonists for obesity. Northstrive Biosciences is evaluating licensing, strategic partnerships, and direct development pathways for clinical advancement, subject to available financing. EL-32 — Preclinical Study Underway In March 2026, Northstrive Biosciences initiated a preclinical study for EL-32, a dual-ac
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
YUVA BIO ENERGY PRIVATE LIMITED | U35106MH2024PTC427363 IndiaFilings Startup Registrations Trademark GST Income Tax MCA Compliance Global Refer & Earn We're Hiring! 🥳 Login Register India Company Register UAE Company Register USA Company Register India Company → Register UAE Company → Register USA Company → Disclaimer The company information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform a
Awards and After Party | in-cosmetics Global | Zylö Therapeutics LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Priv … We are excited that Zylö's Z-pod® technology is shortlisted for the Rising Star Award of In-Cosmetics Global 2024 in Paris! Come visit us at the first-year exhibitor section at stand 1T26 .... https://lnkd.in/eH8spTYS Awards and After Party | in-cosmetics Global in-cosmetics.com 19 2 Comments Like Comment Share Copy LinkedIn Facebook X Cody Reynolds 2y Report this comment Printing my badge now and getting excited for the in-cosmetics Global show in Paris! No more previous con
Elevai Skincare Launches Innovative S-Series Root Renewal System for Hair and Scalp Health | Quiver Quantitative --> Skip to Main Content MEMORIAL DAY API SALE 50% off your first year of Quiver API ... Use Promo Code: MEM50 Quiver API --> × Get a Free Trial on Quiver Premium Today! Upgrade Now Upgrade × Get Email Alerts On ELAB Stock Enter your email to receive free breaking news alerts and insights related to ELAB. Sign Up Now (Free) Home Datasets Most Popular Politician Search Congress Trading 2026 Midterm Elections Donald Trump Stock Trades Election Fundraising Insider Trading G … mmarize this release may make mistakes. See the full release here . $ELAB Hedge Fund Activity We have seen 7 institutional investors add shares of $ELAB stock to their portfolio, and 4 decrease their positions in their most recent quarter. Here are some of the largest recent moves: SABBY MANAGEMENT, LLC added 2,541,779 shares (+inf%) to their portfolio in Q3 2024 WHITTIER TRUST CO OF NEVADA INC removed 80,666 shares (-100.0%) from their portfolio in Q3 2024 GEODE CAPITAL MANA … ons in hair loss we’ve seen in twenty-five years,” marking its first successful application in their new product line 1 . “This system is a testament to our commitment to advancing the science of hair and scalp health,” said Dr. Jordan R. Plews, Chief Executive Officer of Elevai Skincare. “By combining our proprietary PREx Exosomes with Yuva Bio’s Y100 mitochondrial technology, we’ve developed a dual-mechanism solution that promotes follicle rejuvenation and scalp vitality. T
Search - ModernAesthetics YoungMD Connect Subscribe Log In Create Account Back Energy-based Devices Injectables Minimally Invasive Practice Development Regenerative Medicine Skincare Surgical Weight Loss Videos/Podcasts Face Value Updates in Energy-Based Devices RF Microneedling Safety See All Columns Energy-Based Devices Perspectives Injectables Perspectives Surgical Perspectives News Energy-Based Devices Injectables Regenerative Medicine Surgical Weight Loss See All Conferences Music City SCALE Octane ATF See All YoungMD Connect Session Highlights YoungMD Connect Member Articles TOPICS SERIE
Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™ – Company Announcement - FT.com Subscribe Sign In Menu Search Financial Times myFT if you don't need to support both core and enhanced --> Search the FT Search Search the FT Search Close Home World US Companies Tech Markets Climate Opinion Lex Stock Picking Game Life & Arts How To Spend It Sign In Subscribe Markets Markets Data Equities Equities Screener Sectors & Industries Company Announcements Director … ONS AND METHODS FOR THE TREATMENT OF SKIN, SCALP, AND HAIR IMPROVEMENT”, Patent Application Serial No 63/664,517, covers the unique and novel combination of Elevai exosomes and Y100, technologies that the inventors believe are synergistic and could allow significantly better results than either technology used alone. The second patent, “PREPARATIONS INCLUDING LIPID BILAYER NANOPARTICLES”, Patent Application Serial No 63/664,526, covers the use of exosomes (and similar lipid b … ner with a scientific innovator such as Elevai Labs to successfully combine our award winning technologies to create revolutionary new products for the world of medical aesthetics. We look forward to helping people concerned about the signs of aging through use of the Elevai S-Series Root Renewal System.” BosleyMD® has lauded the Y100 technology as “one of the biggest innovations in hair loss we’ve seen in twenty-five years,” marking its first successful application in their … n. Elevai’s Strategic Vision for the Future Elevai Labs is poised to expand the application of their proprietary technologies beyond their current uses. This upcoming product line was recently announced as part of a conference presentation to medical aesthetics professionals by the inventors and scientific co-founders of Elevai Labs and Yuva Biosciences at The Aesthetic Show in Las Vegas, Jordan R. Plews, PhD and Keshav K. Singh, PhD, and the company plans to initiate full-sc
As filed with the Securities and Exchange Commission on September 6, 2024. Registration No. 333-[*]     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933   ELEVAI LABS INC. (Exact name of registrant as specified in its charter)   Delaware   5912   85-1399981 (State or Other Jurisdiction of Incorporation or Organization)   (Primary Standard Industrial Classification Code Number)   (I.R.S. Employer Identification No.)   120 Newport Center Drive, Ste. 250 Newp … n us, but we have not raised sufficient proceeds in this offering to adequately fund the intended uses of the proceeds as described in this prospectus.   In addition, the selling stockholders (the “Selling Stockholders”) are offering an aggregate of 1,299,999 shares of common stock to be sold pursuant to a separate resale prospectus (the “Resale Prospectus”) included in the registration statement of which this prospectus forms a part. We will not … Dr. Stanislav Sokolenko’s Lab at Dalhousie University and a non-repayable Grant from the Mitacs Accelerate Grants Program (“Mitacs”). Mitacs is an organization that funds projects intended to grow research and development initiatives between industry and institutions.   ELV3000 is a two-year research collaboration between Dr. Sokolenko’s Lab and ELEVAI LABS. The primary aim of this research project is to establish novel techniques for characterizi … lexion. Empower™ serum is a concentrated serum, designed specifically for application post ablative procedures and treatments such as such as energy device treatments, mid-depth chemical peels, micro needling, or injectables. Enfinity™ is our continuing care product that we recommend for daily use. Our Enfinity™ daily serum is a stable serum for at-home daily use that contains a blend of Elevai Exosomes™ combined with complementary stem cell growth fac … d Scalp Health   In 2022, Elevai Skincare initiated a study to explore the application of its proprietary exosome technology, originally developed for skin care, in the realm of hair and scalp health. This study, conducted in collaboration with the National Hair Loss Medical Aesthetics under the leadership of Carly Klein, aimed to assess the
%PDF-1.5 %���� 1084 0 obj > endobj 1197 0 obj >/Filter/FlateDecode/ID[ ]/Index[1084 222]/Info 1083 0 R/Length 364/Prev 5438937/Root 1085 0 R/Size 1306/Type/XRef/W[1 3 1]>>stream h����+Dq����\3e�!6 �I�Lٱ �X��$��Ȃ�dC�x�XX�ң�P� �(Y�$;��|��YZX��������sϽֈDĊU�S�+5 S۪mQM��1�3jaZu�Ȕ� ���$�qw�>t��j"�Ff�����2X�H �^�k=M���]5���%�Gev#�7���nc��f�ح��@]f�����yfp��igcמn���)��}�Ub6o7ɤ�.� {�l�wMkֻg2 L�s�����4V���.1:l��L�u� �|h���Ƒ-��S��?!�@7���)�:\ᛯ_�$&5.z�|�k$xɟ#&g���~�O��"��? n�?� endstream endobj startxref 0 %%EOF 1305 0 obj >stream hޤ�_lSU ǿ��v-�Mwo{�� ^Z�0l���D�0'$&t�@ f��E����� �lZ … ⬊YŬ�5�&�3��⊹"fgEΊ�9+vV��G��f M>�}4�h����G���8�!�O��o�|���B�6ƫ�G�� >stream application/postscript 21640 - Mitochondria Targeted Therapeutics logo_NEW Daniel Elliott 2021-10-12T13:56:59+01:00 2021-10-12T13:56:59+01:00 2021-10-12T13:56:59+01:00 Adobe Illustrator 25.2 (Macintosh) xmp.iid:a381136a-f33c-4861-bce5-53a1a70e200f xmp.did:a381136a-f33c-4861-bce5-53a1a70e200f uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf xmp.iid:9c21ad0e-4af9-4448-b973-8db87d0ef907 xmp.did:9c21ad … 610890 2020-11-26T17:40:54Z Adobe Illustrator 24.0 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:4eed2328-5be5-40b8-b3fa-160472aa31c3 2020-12-14T11:34:53Z Adobe Illustrator 25.0 (Macintosh) / saved xmp.iid:ebf93fd6-38ad-469f-98ed-33d16b216654 2021-10-12T09:20:47+01:00 Adobe Illustrator 25.2 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:9c21ad0e-4af9-4448-b973-8db8 … 7 2021-10-12T13:55:01+01:00 Adobe Illustrator 25.2 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator saved xmp.iid:a381136a-f33c-4861-bce5-53a1a70e200f 2021-10-12T13:56:59+01:00 Adobe Illustrator 25.2 (Macintosh) / converted from application/postscript to application/vnd.adobe.illustrator Print Adobe Illustrator Adobe PDF library 15.00 1 True False 444.762974 201.626845 Millimeters NexaLight Nexa Light Regular Open Type Version 1.000 Fal … ƽ�;���M���P���+����9ę� T6L�wr,�~ ��f endstream endobj 1147 0 obj >stream application/postscript Print Daniel Elliott 2017-06-21T21:22:05+01:00 2017-06-21T21:22:05+01:00 2017-06-21T21:22:04+01:00 Adobe Illustrator CC 2015 (Macintosh) xmp.iid:6fd5c0ba-886c-4847-a42f-d9f2d2a03e85 xmp.did:6fd5c0ba-886c-4847-a42f-d9f2d2a03e85 uuid:5D20892493BFD
Yuva Biosciences: Business Model Canvas – businessmodelcanvastemplate.com Skip to content Framework Templates Blogs Search Cart 0 / $0.00 Home Biotechnology Yuva biosciences business model canvas template research YUVA BIOSCIENCES BUSINESS MODEL CANVAS TEMPLATE RESEARCH Digital Product Download immediately after checkout Editable Template Excel / Google Sheets & Word / Google Docs format For Education Informational use only Independent Research Not affiliated with referenced companies Refunds & Returns Digital product - refunds handled per policy YUVA BIOSCIENCES BUNDLE Get the Full Pack
Contact – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Contact Get in Touch To ask any question or submit your resume for any job openings at Yuva Biosciences, please fill out the contact form below. We will do our best to reply to as many inquiries as possible. Full Name Email Choose File Phone Number Message SUBMIT Home About Us News Careers Contact Home About Us News Caree
Yuva Biosciences - Longevity List Sign in or Register Add a listing View all results No results Jobs Database More arrow_drop_down Clinical Trials Newsletter Coworking Events Blog Supporters About Add a listing opening tag is omitted --> tag --> Yuva Biosciences Mitochondrial cosmeceuticals and pharmaceuticals Website Profile prev next Website Bookmark Share prev next General Headquarters Birmingham, Alabama, United States of America Founders & Team Keshav K. Singh Year Founded 2019 Company type Private company Technical Details Aging Target Mitochondrial dysfunction Product modality drugs, co
Careers – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Careers Openings Positions listed below may be available at Yuva Biosciences’ Birmingham location near UAB. Candidates at the Principal Research Scientist and Research Scientist level are expected to be self-motivated, resourceful and should hold an MD or PhD degree. Those with experience in drug screening, assay developm … dling, breeding, mitochondrial biology, and genetics are strongly encouraged to apply. Research Scientist, Assay Development Associate Research Scientist/Operations Manager To apply please submit your resume using the form on the Contact Us Page. Home About Us News Careers Contact Home About Us News Careers Contact Company HQ/Lab:1500 First Avenue N, Suite L133, Birmingham, AL 35203 +New York City and Boston Copyright © 2026 All rights reserved. Developed by Aziz Bhatti
Calecim Archives | Hair Loss Cure 2020 Skip to content Hair Loss Cure 2020 Search Primary Menu Home About Products Best Laser Hair Growth Devices Hair Research Best Hair Loss Shampoos Contact Us Privacy Policy Search for: Category Archives: Calecim Calecim , Elevai Labs , Exosomes Topical Exosomes for Hair Growth June 18, 2026 admin 112 Comments In 2019 when I first discussed exosomes for hair growth , most doctors were injecting them into the scalp. Recently, I also discussed the rarer intravenous (IV) delivery of exosomes to tackle hair loss. Now I look at the topical application of exosome
Yuva Biosciences, Inc. - HQ | The Org Platform Enrich Pricing Log in Sign up Yuva Biosciences, Inc. Offices HQ Unverified HQ 3 people · 0 jobs Yuva Biosciences, Inc.'s headquarters in Birmingham, AL, United States Office location People ( 3 ) Keshav K Singh, PhD Scientific Founder L Chief Scientific Officer Saksham Narang Vice President Leopoldo Aguilera-Aguirre Principal Research Scientist Jobs ( 0 ) No jobs in this office Other offices View all offices No other offices Company About Contact Blog Business Solutions Trust Pricing Directory Companies People Features Employer Branding Pro
Associate Research Scientist / Operations Manager - Longevity List Sign in or Register Add a listing View all results No results Jobs Database More arrow_drop_down Clinical Trials Newsletter Coworking Events Blog Supporters About Add a listing opening tag is omitted --> tag --> Associate Research Scientist / Operations Manager Yuva Biosciences Full time Birmingham, Alabama Posted: August 5, 2020 Job Link Details prev next Go to Job Bookmark Share prev next Company Yuva Biosciences Yuva Biosciences, Inc. is seeking an exceptional hands on associate research scientist/operations manager to overs
EL-22 / MOA Life Plus, PMGC Holdings, NorthStrive Biosciences EL-22 / MOA Life Plus, PMGC Holdings, NorthStrive Biosciences - LARVOL DELTA Home Next Prev 1 to 15 Of 15 Go to page 1 June 18, 2026 NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets (Yahoo Finance) - "Filed applications include claims directed to the use of EL-22 and EL-32 for preserving lean muscle mass during GLP-1 and obesity-related weight loss; Filed applications include combination and co-administration approaches, including taki … sociated with muscle support....The applications have been assigned U.S. Patent Application Nos. 19/709,895 (EL-22) and 19/709,950 (EL-32)....These human-use filings build on and differentiate the portfolio from NorthStrive's previously announced animal-focused filings, seeking to extend the EL-22 and EL-32 inventions to human patients and the growing GLP-1 and obesity-related weight loss market." Patent • Obesity Print Email More sharing Reddit StumbleUpon Delicious March 27 … Fusion Protein of Myo-2 for Use in Encouraging Muscle Growth in Animals (Patent Application No. 19/191,246); (ii) EL-32 in Obesity as Monotherapy and Combination with GLP-1: Updated patent filings for Pharmaceutical Composition for Treatment of Muscle Loss Due to Obesity Treatments (Patent Application No. 19/191,209), and Combination Therapy for Treatment of Muscle Loss Due to Obesity Treatments utilizing GLP-1 receptor agonists (Patent Application No. 19/191,226); (iii) EL-3 … (iii) EL-32 in Animals: Animal Feed Additive to Encourage Muscle Growth (Patent Application No. 19/191,258)." Patent • Obesity Print Email More sharing Reddit StumbleUpon Delicious April 24, 2025 Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment (GlobeNewswire) - "Northstrive Biosciences..announced that it has received preliminary respon … rego the pre-IND meeting. Northstrive aims to file the Investigational New Drug application in 2025 and thereafter initiate a Phase 2 clinical trial..." FDA event • IND • New P2 trial • Obesity Print Email More sharing Reddit StumbleUpon Delicious March 10, 2025 Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.26.1 Commitments and Contingencies 12 Months Ended Dec. 31, 2025 Commitments and Contingencies Disclosure [Abstract]   Commitments and Contingencies NOTE 11 – COMMITMENTS AND CONTINGENCIES   Elevai Royalties In conjunction with the Elevai Acquisition, the Company will pay the Seller the Royalties (as defined in Note 4) for each year ending on the anniversary of the Elevai Closing Date during the five-year period following the Elevai Closing. The Royalties earned with respect to each fiscal year are payable within five business days of the f
A4LI 2025 D.C. Summit Recap - Alliance for Longevity Initiatives Skip to content Dylan V. Livingston and former Speaker Newt Gingrich Discuss Prioritization of Longevity Science Join A4LI Become a Member Become a Sponsor Get Involved Our Advocacy Publications Longevity Science Caucus Podcasts H-SPAN Podcast Scientific Spotlights About Events A4LI H-SPAN Summit D.C. Past Events A4LI Longevity Investors Summit A4LI 2025 D.C. Summit Recap DC Fly-In 2024 Geroscience Education Reception LogIn Join A4LI Become a Member Become a Sponsor Get Involved Our Advocacy Publications Longevity Science Caucus … etr Sramek MBA, Co-founder, Chairman and Managing/General Partner Longevitytech.fund Joan Mannick, MD Co-Founder and CEO Tornado Therapeutics Chris Bradley, MS Co-Founder and CEO Matter Bio Jasmine Smith CEO Rejuve.AI Christopher Steele Ph.D, CSO Medical Technology Enterprise Consortium (MTEC) Vera Gorbunova Ph.D, Professor University of Rochester Natalia Mitin Ph.D, Co-Founder and CEO Sapere Bio Dobri Kiprov MD, CMO Lifespan Edge Niklas Anzinger Co-Founder and CEO Infinita C … Brenda Eap, PhD Karl Pfleger, PhD Angel Investor Petr Sramek, MBA LongevityTech.Fund Alexandra Bause, PhD Apollo Health Ventures 5:30 PM - 7:00 PM Networking April 29th Applications of Longevity Medicine 8:30 AM - 8:55 AM Morning Networking 8:55 AM - 9:00 AM Watch now! Opening Remarks Dylan V. Livingston Founder and CEO, A4LI 9:00 AM - 9:35 AM Watch now! The Global Longevity Economy Moderator Michael Ringel JD, PhD COO, Life Biosciences Raiany Rommani Longevity Policy & E … General Partner at NFX Petr Sramek, MBA Co-Founder and Chairman, Longevitytech.fund Karl Pfleger, PhD Founder, Agingbiotech.info 2:55 PM - 3:00 PM Coffee Break 3:00 PM - 3:40 PM Watch now! Startup Stories — Paths to Funding Moderator Sonia Arrison Founder, 100 Plus Capital Mac Davis Founder and CEO, Minicircle Jasmine Smith CEO, RejuveAI Joe Betts-LaCroix CEO, Retro Biosciences 3:40 PM - 4:15 PM Watch now! Legal Perspectives in Longevity Science Moderator Thomas Zuber, JD Ma … he small business community, Kesselring received the 2022 SBA District Director Award for his work supporting small business owners across the country through SCORE and affiliated organizations, with a particular focus on helping businesses establish an online presence during the COVID-19 shutdown. He is also an alumnus of the Goldman Sachs 10,00
Yuva Biosciences: Business Model Canvas – businessmodelcanvastemplate.com Skip to content Framework Templates Blogs Search Cart 0 / $0.00 Home Biotechnology Yuva biosciences business model canvas template research YUVA BIOSCIENCES BUSINESS MODEL CANVAS TEMPLATE RESEARCH Digital Product Download immediately after checkout Editable Template Excel / Google Sheets & Word / Google Docs format For Education Informational use only Independent Research Not affiliated with referenced companies Refunds & Returns Digital product - refunds handled per policy YUVA BIOSCIENCES BUNDLE Get the Full Pack
NorthStrive Biosciences Advances to Phase III of AI-Driven --> Accessibility: Skip TopNav NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries 17. Dezember 2025 07:30 ET | Quelle: PMGC Holdings Inc. PMGC Holdings Inc. Phase III is intended to generate meaningful biological data on potential drug compounds prioritized by YuvaBio’s classifier, which applies proprietary machine-learning methods to identify candidates targeting muscle preservation through improvements in mitochondrial function.
Corsera Health combines RNAi, AI tech to create 'a world without cardiovascular disease' | FirstWord HEALTHTECH You need to enable JavaScript to run this app. Loading...
NorthStrive updates AI Phase III timeline to Q2 2026 | ELAB Stock News --> STOCK TITAN Login Sign up Login Sign up 0 HOME --> NEWS FEED Stock News Live Stock News Today Trending News AI news FDA Approvals Clinical Trials Crypto News Merger & Acquisitions Earnings Offerings IPO News Stock Splits Top News - Gainers Top News - Losers SEC FILINGS SEC Filings Live SEC Filings Today Form 4 - Insider Trading 8-K - Material Events 10-K - Annual Reports 10-Q - Quarterly Reports DEF 14A - Proxy Statements S-1 - IPO Registration S-3 - Shelf Registration STOCKS All Stock Themes AI Stocks Crypto Stocks Oil … Holdings (NASDAQ: ORBS) Reports Total Holdings of Approxi... DLHC DLH Contract Award Opens New Growth Channels with U.S Navy RKLB NASA Selects Rocket Lab to Launch Sun, Earth Sciences Missions ILLR Triller Group (Nasdaq: ILLR): The Reverse Split Is Not the Story ... SHPH United Dogecoin Advances Data Centre and Power Infrastructure Str... ON onsemi to Acquire Synaptics to Enable the Next Generation of Inte... BMNR ORBS Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings o … Holdings (NASDAQ: ORBS) Reports Total Holdings of Approxi... DLHC DLH Contract Award Opens New Growth Channels with U.S Navy Previous Next --> Overview Financials News SEC Filings NorthStrive Biosciences Announces Progress Updates to Phase III Timeline for AI-Driven Drug Discovery Program with Yuva Biosciences Rhea-AI Impact (High) Rhea-AI Sentiment (Neutral) Tags clinical trial AI Rhea-AI Summary English Arabic French German Italian Korean Spanish NorthStrive Biosciences (N … ne for ELAB extended beyond the initial 6–9 weeks? The timeline was extended to apply upgraded AI classifier models. According to NorthStrive Biosciences, Yuva’s improved sixth‑generation models increase screening accuracy and sensitivity, requiring more comprehensive in‑vitro evaluation and longer validation to strengthen candidate selection. Does NorthStrive control the revised Phase III timetable announced for ELAB? No, NorthStrive does not control the revised timetable. A
TBD Angels — Portfolio & Investments | Fundable fundable. DATA PLATFORM Dashboard Companies People Investment Firms Angels & Partners COLLECTIONS Lists Saved Searches Hiring Lists WORKFLOWS Deal Alerts Integrations API + Credits Toggle Sidebar Overview Highlights Investments Team TBD Angels Investments 11 Lead Investments 5 TBD Angels is a group of like-minded angel investors who thrive on sharing advice, guidance, and capital with talented entrepreneurs. TBD Angels provide critical advice and connections to jumpstart the companies it invests in. Founded 2020 North America, United Stat
ELAB 8-K & SEC Filings - Yahoo Finance Oops, something went wrong Skip to navigation Skip to main content Skip to right column Yahoo Finance Canada News Finance Sports More News Today's news World Cup Canada Politics World U.S. Weather Science & Tech Videos Lifestyle Shopping Gift Guide Health & Wellness Relationships Travel Food Entertainment Movies TV Music Celebrity Finance My portfolio Watchlists Markets News Screeners Industries Taxes Real estate Currency converter Sports Fantasy NHL MLB NBA NFL CFL Soccer Tennis Golf MMA Sign in My Stocks News Housing Technology Markets Stock
Elevai Labs Archives | Hair Loss Cure 2020 Skip to content Hair Loss Cure 2020 Search Primary Menu Home About Products Best Laser Hair Growth Devices Hair Research Best Hair Loss Shampoos Contact Us Privacy Policy Search for: Category Archives: Elevai Labs Calecim , Elevai Labs , Exosomes Topical Exosomes for Hair Growth June 18, 2026 admin 112 Comments In 2019 when I first discussed exosomes for hair growth , most doctors were injecting them into the scalp. Recently, I also discussed the rarer intravenous (IV) delivery of exosomes to tackle hair loss. Now I look at the topical application of … with an average rating of 3.9 out of 5 stars praise the product’s ease of application, non-irritation and non-greasiness. Also see the announcement on Linkedin . Yuva Biosciences developed this topical foam based hair loss product as follows: “Using AI, the company combed through thousands of molecules to identify those with the greatest potential to boost mitochondria levels in skin and hair cells, leading to the discovery of its lead compound, Y100.” Among
Do you work in bioscience?... - Birmingham Business Alliance Facebook Log In Birmingham Business Alliance's Post Birmingham Business Alliance February 13, 2025 · Shared with Public Do you work in bioscience? If so, this one's for you! On Thursday, March 20 from 8:30 to 10:30 a.m. at Innovation Depot , join us for our first Beakers & Brews of the year! Unlike previous Beakers & Brews, this one will be a coffee hour, where you can fuel up on brews provided by Cala Coffee . While you sip on your morning brew, hear from Yuva Biosciences Vice President Saksham Narang on the compan
Greg Schmergel – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Greg Schmergel Board of Directors , Management Team Greg Schmergel is a serial entrepreneur who has started multiple companies, including Nantero, Inc. (one of the world’s leading nanotechnology companies), ExpertCentral.com, and Tower Group. He serves on multiple Boards including as member of the Board of Tr … red by Reuters). Greg was a previous Ernst & Young Entrepreneur of the Year Award winner in New England, in the emerging technology category, and was also inducted into Boston Business Journal’s 40-under-40 Hall of Fame in 2018. Greg stays active in supporting the entrepreneurship and business community including being a judge in the Harvard Business School New Venture Competition and at the MassChallenge accelerator, a guest speaker at entrepreneurial classes and groups,
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
Yuva Biosciences Stock Price, Funding, Valuation, Revenue & Financial Statements Technology Vendors Recent Research Newsletter Media Support Login Who We Serve Function Corporate Strategy Corporate Venture Capital Venture Capital IT Corporate Innovation How VCs Use CB Insights Go to the video gallery → Industries Consumer & Retail Tech Insurance Healthcare Industrials Financial Services Professional Services Professional Services Learn More → Success Stories How We Help Understand Tech Markets Anticipate Competitor Strategy Determine Tech Strategy Connect with Tech Vendors & Partne … 024 Incubator/Accelerator Subscribe to see more $XXM 0 FY undefined 10 7/3/2024 Grant Subscribe to see more $XXM 0 FY undefined 10 11/7/2023 Seed VC $XXM Subscribe to see more $XXM 0 FY undefined 10 1/1/2022 Debt Subscribe to see more $XXM 0 FY undefined 10 Date 3/24/2026 10/1/2024 7/3/2024 11/7/2023 1/1/2022 Round Convertible Note Incubator/Accelerator Grant Seed VC Debt Amount $1.12M $XXM Investors Undisclosed Investors Subscribe to see more Subscribe to see more Subscribe … or Incubator/Accelerator Alabama 00/00/0000 00/00/0000 Therapeutics Development Fund Subscribe to see more Incubator/Accelerator Alabama 00/00/0000 00/00/0000 TBD Angels Subscribe to see more Angel Investor (Group) Massachusetts 00/00/0000 00/00/0000 Atma Capital Subscribe to see more Asset/Investment Management California 00/00/0000 00/00/0000 VentureSouth Subscribe to see more Venture Capital South Carolina First funding 10/1/2024 00/00/0000 00/00/0000 00/00/0000 00/00/0000 … 0/0000 00/00/0000 00/00/0000 Investor Innovation Depot Therapeutics Development Fund TBD Angels Atma Capital VentureSouth Rounds 1 Incubator/Accelerator Subscribe to see more Subscribe to see more Subscribe to see more Subscribe to see more Board Seats Type Incubator/Accelerator Incubator/Accelerator Angel Investor (Group) Asset/Investment Management Venture Capital Location Alabama Alabama Massachusetts California South Carolina Learn more by requesting a demo Loading... 498
Posts with replies by Yuva Biosciences, Inc. (@YuvaBio) / X Log in Sign up Yuva Biosciences, Inc. @YuvaBio Birmingham, Alabama yuvabio.com Joined April 2019 17 Following 140 Followers Posts Replies Media
BIO Alabama - DR. KESHAV K. SINGH JOINS ALLERGAN AESTHETICS SCIENCE OF AGING(SM) FACULTY Menu Log in Home 2026 Annual Conference Investor Opportunities Tapping Into Bioscience Talent Pool AIDT Events BIO Alabama Brief Job Board About Board of Directors About Alabama's Biotech Industry Membership Join BIO Alabama BIO Business Solutions News Ecosystem Contact Log in with Facebook --> Log in with Google Log in with Microsoft Log in with Apple Remember me Forgot password Home 2026 Annual Conference Investor Opportunities Tapping Into Bioscience Talent Pool AIDT Events BIO Alabama Brief Job Boa … arnered national and international recognition because of its potentially broad application. Yuva Biosciences was selected as the most recent UAB Faculty Startup of the Year, as Dr. Singh is the Joy and Bill Harbert Endowed Chair and Director of Cancer Genetics at the University of Alabama at Birmingham. About Allergan At Allergan Aesthetics, an AbbVie company (NYSE: ABBV), we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aes
Speaker Details: 2020 BIO Alabama Virtual Annual Conference x Speaker Details Full Name Saksham Narang Job Title Venture Advisor Company or Organization The University of Alabama at Birmingham Speaker Bio Saksham Narang is a Venture Advisor to the University of Alabama at Birmingham (UAB), as well as the Director of Strategy and Development for Yuva Biosciences. He is co-chairing the startup committee for BIO Alabama. At UAB, Saksham assists in navigating the transition for a technology from the University setting to becoming a startup in the Birmingham ecosystem. He equips entrepreneurs with … tment bank in Boston and was involved in its transition to a first-time venture fund, which successfully raised approximately $50 million in its initial closing. He had various responsibilities at the fund and assisted with fundraising, deal flow, structuring, financial modeling, and reporting. Saksham also worked with the portfolio companies in developing commercialization strategies. He attended Boston University and graduated with a Bachelor of Science in 2015. Speaking At
Uncategorized – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Category: Uncategorized “This Serum Actually Regrew My Thinning Postpartum Hair,” Wall Street Journal, August 22, 2025. “Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases” April 10, 2025. Yuva Biosciences Receives Prestigious Ther … ” April 10, 2025. Yuva Biosciences Receives Prestigious Therapeutic Development Fund Grant from Southern Research to Address Ovarian Aging,July 6, 2024 “New Hair-Loss Biotechnology Has Hit the Mass Market,” American Salon, May 7, 2024. “Yuva Bio raises $7.5m and partners on hair loss treatment targeting mitochondrial dysfunction,” Longevity.Technology, February 26, 2024. “One of the Biggest Innovations in Hair Loss We’ve Seen in Twenty-Five Years” — BosleyMD® Teams With Start … ment with Yuva Biosciences,” November 29, 2023. YuvaBio won the People’s Choice Award at the Octane Aesthetics Tech Forum in Newport Beach, CA. January 26, 2023. Yuva Biosciences To Present Revolutionary Technology at Octane’s Aesthetics Tech Forum, January 26, 2023. “How Dr. Keshav Singh became a pioneer of mitochondria research,” Global Indian, November 25, 2022. Next → Home About Us News Careers Contact Home About Us News Careers Contact Company HQ/Lab:1500 First Aven
Northstrive Biosciences and Yuva Biosciences Complete Phase II of AI Development Program for Novel Treatments in Obesity and Cardiac Diseases | Quiver Quantitative --> Skip to Main Content MEMORIAL DAY API SALE 50% off your first year of Quiver API ... Use Promo Code: MEM50 Quiver API --> × Get a Free Trial on Quiver Premium Today! Upgrade Now Upgrade × Get Email Alerts On ELAB Stock Enter your email to receive free breaking news alerts and insights related to ELAB. Sign Up Now (Free) Home Datasets Most Popular Politician Search Congress Trading 2026 Midterm Elections Donald Trump
Great week for Longevity initiatives in the US! Attention Elevated. The Alliance for Longevity Initiatives organized a series of meetings with members of Congress (65 meetings!) and a hearing with… | Petr Sramek LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases - PMGC PMGC holdings Home Investors Back SEC Filings Governance Corporate Directory Downloads News Back News 2026 News 2025 News 2024 News 2023 News 2022 News 2021 Our History subpages banner 456 We rely on the capital markets for the growth of our brands. Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases Northstrive Biosciences and Yuva Biosciences’ collaboration will leve … putational findings for biological activity on custom assays. YuvaBio will also grant Northstrive an exclusive, worldwide license to this developed technology to derive therapeutic products for cardiac diseases and obesity. Through this collaboration, the parties aim to integrate new methodologies into mitochondrial biology and discover outputs to expand Northstrive’s cardiometabolic disease pipeline. The AI Development Program will combine YuvaBio’s proprietary AI platform w
TBD Angels | Portfolio, Investments & AUM | Caplight NEW Caplight raises a $16M Series A, led by BlackRock and Fin Capital → Products Solutions Resources Log in Book a demo Investors TBD Angels TBD Angels Boston, Massachusetts tbdangels.com Overview TBD Angels is an angel investor group comprised of operators at leading startups and executives at major companies. They provide advice, guidance, and capital to talented entrepreneurs, focusing on early-stage ventures. TBD Angels is industry-agnostic, but focuses on deals where they have deep connections and insights. Year Founded 2020 Portfol
Life Science Fund I | First Avenue Ventures Funds Life Science Fund I Opportunity Fund News Nth Round Investor Portal Select Page Life Science Fund I The First Avenue Ventures Life Science Fund was formed to identify early-stage investment opportunities in the life sciences primarily throughout Birmingham and the State of Alabama. The principals of the Fund will leverage their extensive network, including strategic relationships with research institutions in Birmingham to source investment opportunities and to provide access to resources that assist a portfolio company in navigating the dynami … s of venture development. While our aim is to produce financial returns for the Fund’s Limited Partners, the Principals believe there are several objective success measures. For example, investing in healthcare – specifically the life sciences — ought to create an industry-specific mandate of improving the well-being of society. By making responsible investments in the life sciences, we hope to commit to this mission while achieving excess returns from the activity. The … to commit to this mission while achieving excess returns from the activity. The Fund’s strategic focus in Birmingham and UAB will also create a positive impact. The Principals’ passion for the ecosystem and subject matter is a catalyst for investors, entrepreneurs, and community stakeholders. The Fund is Closed for Investors. Portfolio Companies Acclinate Alveolus Bio ARCHimedes Vascular Compression Works Cytosite Biopharma Diamond Therapeutics GeneCapture ImmPrev Bio Jana Ca
Greenville-based VentureSouth invested in 30 early-stage companies in 2023 - UPSTATE BUSINESS JOURNAL Business News Finance Insight Columns Milestones New to the Street Planner The List TBA Workforce Commercial Real Estate Dealmakers Square Feet Manufacturing / Tech Jumpstart Made Here Tech and Innovation People / Profiles Behind the Brand Events Leaders Library On the Move Profiles Retail / Hospitality Resources Business License Reports Meeting and Event Planning Resources Advertise COMMUNITY JOURNALS GREENVILLE JOURNAL TOWN ATHOME Subscribe Print Issues Business News Finance Insight Columns … t publications. GET STARTED! UPSTATE BUSINESS JOURNAL Contact Us Our team Legal Submit News Sponsorship Request Advertise Upstate South Carolina Business News | Terms of Service Search for: Search Input your search keywords and press Enter. Total 0 Share 0 0 0 0
Fred Ehrsam – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Fred Ehrsam Board of Directors Fred Ehrsam is currently working on a paradigm for human physical and mental wellness. He invests in early stage businesses across a variety of industries. Fred is an advisor to numerous new ventures, small companies and non-profits. Mr. Ehrsam served as the CEO of V Squared Wind, a star
Yuva Biosciences and BosleyMD New Mitochondrial Upregulation Foam | Hair Loss Cure 2020 Skip to content Hair Loss Cure 2020 Search Primary Menu Home About Products Best Laser Hair Growth Devices Hair Research Best Hair Loss Shampoos Contact Us Privacy Policy Search for: BosleyMD , Elevai Labs , Ken Washenik , Mitochondria , Mitochondrial Function , Yuva Biosciences Yuva Biosciences and BosleyMD New Mitochondrial Upregulation Foam December 9, 2024 admin 43 Comments I covered Yuva Biosciences (US) very briefly in 2018 in my post on mice and hair growth research . The company founder Dr. Keshav S … with an average rating of 3.9 out of 5 stars praise the product’s ease of application, non-irritation and non-greasiness. Also see the announcement on Linkedin . Yuva Biosciences developed this topical foam based hair loss product as follows: “Using AI, the company combed through thousands of molecules to identify those with the greatest potential to boost mitochondria levels in skin and hair cells, leading to the discovery of its lead compound, Y100.” Among
Northstrive Biosciences Signs Partnership with Yuva --> Accessibility: Skip TopNav Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases April 10, 2025 08:00 ET | Source: PMGC Holdings Inc. PMGC Holdings Inc. Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova™, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel pharmaceutical treatments for obesity, type 2 diabetes and other cardiometabolic conditions. Northst … putational findings for biological activity on custom assays. YuvaBio will also grant Northstrive an exclusive, worldwide license to this developed technology to derive therapeutic products for cardiac diseases and obesity. Through this collaboration, the parties aim to integrate new methodologies into mitochondrial biology and discover outputs to expand Northstrive’s cardiometabolic disease pipeline. The AI Development Program will combine YuvaBio’s proprietary AI platform w
424B3 1 ea0215355-424b3_elevai.htm PROSPECTUS Filed Pursuant to Rule 424(b)(3) Registration No. 333-281987 PROSPECTUS 1,299,999 Shares of Common Stock Elevai Labs Inc. This prospectus relates to the resale of 1,299,999 shares of common stock, par value $0.0001 per share, by the selling stockholders (the “Selling Stockholders”) of Elevai Labs Inc. We will not receive any proceeds from the sale or other disposition of shares by the Selling Stockholders. Our common stock is listed on The Nasdaq Capital Market under the symbol &ld … Dr. Stanislav Sokolenko’s Lab at Dalhousie University and a non-repayable Grant from the Mitacs Accelerate Grants Program (“Mitacs”). Mitacs is an organization that funds projects intended to grow research and development initiatives between industry and institutions. ELV3000 is a two-year research collaboration between Dr. Sokolenko’s Lab and ELEVAI LABS. The primary aim of this research project is to establish novel techniques for characterizi … lexion. Empower™ serum is a concentrated serum, designed specifically for application post ablative procedures and treatments such as such as energy device treatments, mid-depth chemical peels, micro needling, or injectables. Enfinity™ is our continuing care product that we recommend for daily use. Our Enfinity™ daily serum is a stable serum for at-home daily use that contains a blend of Elevai Exosomes™ combined with complementary stem cell growth fac … d Scalp Health In 2022, Elevai Skincare initiated a study to explore the application of its proprietary exosome technology, originally developed for skin care, in the realm of hair and scalp health. This study, conducted in collaboration with the National Hair Loss Medical Aesthetics under the leadership of Carly Klein, aimed to assess the potential of topical Elevai Exosomes™ in addressing hair loss and improving scalp health. Details of the Study … hip with Yuva Biosciences We were honored with the People’s Choice Award at the 2022 Octane Aesthetic Technology Forum, then in 2023, Yuva Biosciences won the 2023 People’s Choice Award at the same event. This recognition catalyzed a discussion on shared vision, leading to a partnership with Yuva, and the collaboration was seen
Yuva Biosciences Inc. Pink Sheet Scrip Medtech Insight HBW Insight Generics Bulletin In Vivo Sign In Free Trial Sign In Free Trial Pink Sheet Scrip Medtech Insight HBW Insight Generics Bulletin In Vivo Yuva Biosciences Inc. https://yuvabio.com Industry Biotechnology See more in Biomedtracker Latest on Yuva Biosciences Inc. Already A Biomedtracker Subscriber? You have access to the full company record through your subscription. Go To Biomedtracker Twitter feed RSS feed RSS feed Podcast Spotify About About Us Opens in new window Meet the Team Editorial Standards Award-Winning Journalism Help Adv
IMCAS - Congresses on Dermatology and Aesthetic & Plastic Surgery Academy Webinaires Bibliothèque Magazine Insider Podcasts Rapport Sponsoriser Academy Academy Webinaires Bibliothèque Magazine Insider Podcasts Rapport Sponsoriser Vidéothèque Revenir en arrière Filtré par: Alopécie (chute de cheveux) Trier par Filtrer par événement Filtrer par langues Démonstrations uniquement Vidéos Stetix Vidéos auxquelles j'ai accès Chirurgie du corps Chirurgie du corps Chirurgie du visage Chirurgie du visage Chirurgie mammaire Chirurgie mammaire Cosméceutiques & nutraceutiques Cosméceutiques Dermatologi … propos L'histoire de la marque IMCAS Partenaires Scientifiques Avis IMCAS Fund Découvrez IMCAS Academy Webinaires Bibliothèque Magazine Insider Podcasts Suivez IMCAS Besoin d'aide ? Contactez-nous Lire les FAQs Politique de confidentialité Informations juridiques © 2026 IMCAS International Master Course on Aging Science. Tous droits réservés. Accessibilité : non conforme Congrès IMCAS Asia 2026 IMCAS China 2026 IMCAS World 2027 IMCAS Americas 2027 Découvrez IMCAS A … propos L'histoire de la marque IMCAS Partenaires Scientifiques Avis IMCAS Fund Besoin d'aide ? Contactez-nous Lire les FAQs Politique de confidentialité Informations juridiques Suivez IMCAS © 2026 IMCAS International Master Course on Aging Science. Tous droits réservés. Accessibilité : non conforme Traitement en cours, veuillez patienter... Erreur Veuillez remplir tous les champs requis. Voici les champs manquants : OK IMCAS Rechercher... Ouvrir le menu Congrès IMC … ? Avis Ils parlent de nous FAQ Consultez notre FAQ Contact Aide & support IMCAS Fund Adhésion Se connecter fr IMCAS Fermer le menu Congrès Academy Community À propos Adhésion IMCAS Asia 2026 19 - 21 juin 2026, BANGKOK & ONLINE IMCAS China 2026 27 - 29 août 2026, SHANGHAI IMCAS World 2027 28 - 30 janvier 2027, PARIS & ONLINE IMCAS Americas 2027 20 - 22 mai 2027, SãO PAULO INVEST by IMCAS 2027 27 janvier 2027, PARIS Webinaires Accès en direct et à la demande aux dernières avanc
IMCAS - Congresses on Dermatology and Aesthetic & Plastic Surgery Academy Webinars Library Insider magazine Podcasts Report Sponsor Academy Academy Webinars Library Insider magazine Podcasts Report Sponsor Access is restricted to physicians To watch this video, please sign in Sign in Do not have an account yet? Create your IMCAS account Go back Innovation Tank 2025 Start-up competitor: Raziel Therapeutics - Injectable for fat reduction Share Alon BLOOMENFELD Industry representative Israel Disclosures - Alon BLOOMENFELD > Did you receive any funding to support your research for this TOPIC? … 27 IMCAS Americas 2027 About The IMCAS story Scientific Partners Feedback IMCAS Fund Discover IMCAS Academy Webinars Library Insider magazine Podcasts Follow IMCAS Need assistance? Contact us Read FAQs Privacy policy Legal information © 2026 IMCAS International Master Course on Aging Science. All rights reserved. Accessibility : non-compliant Congresses IMCAS Asia 2026 IMCAS China 2026 IMCAS World 2027 IMCAS Americas 2027 Discover IMCAS Academy Webinars Library Insider magazi … ider magazine Podcasts About The IMCAS story Scientific Partners Feedback IMCAS Fund Need assistance? Contact us Read FAQs Privacy policy Legal information Follow IMCAS © 2026 IMCAS International Master Course on Aging Science. All rights reserved. Accessibility : non-compliant Processing, please wait... Error Please fill out all required fields. Here are the fields that are missing: OK IMCAS Search... Open menu Congresses IMCAS Asia 2026 19 - 21 June 2026 BANGKOK & ONLIN … us FAQ View our most Frequently Asked Questions Contact How can we help? IMCAS Fund Membership Sign in en IMCAS Close menu Congresses Academy Community About Membership IMCAS Asia 2026 19 - 21 June 2026, BANGKOK & ONLINE IMCAS China 2026 27 - 29 August 2026, SHANGHAI IMCAS World 2027 28 - 30 January 2027, PARIS & ONLINE IMCAS Americas 2027 20 - 22 May 2027, SãO PAULO INVEST by IMCAS 2027 January 27th, 2027, PARIS Webinars Live and on-demand access to the latest in aesthetic
#mitochondria #genetics #aging #longevity #cancerresearch #biology #biotech #science #stem #research #podcast #podcasts #scicomm #sciencecommunication | Marie McNeely, PhD LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject A
#009: Keshav Singh & Greg Schmerge (Yuva Biosciences) - April 15th, 2021 – The Longevity Biotech Show – Lyssna här – Podtail Hem --> Topplista Avsnitt Podcasts Logga in Registrera Om Podtail FAQ Partners Copyright Policy Föreslå en podcast #009: Keshav Singh & Greg Schmerge (Yuva Biosciences) - April 15th, 2021 15 apr 2021 · The Longevity Biotech Show 01:22:20 Keshav Singh (University of Alabama) and Greg Schmergel (Nantero) are the co-founders of Yuva Biosciences, an early-stage biotech company developing drugs and natural compounds to reverse … sity)Greg Fahy (Intervene Immune)David Gobel (Methuselah Foundation, Methuselah Fund) Hosted by: Laura Minquini (MYKIGAI, Let's Talk Longevity), Avi Roy (Oxford University), and Nathan Cheng (Longevity Marketcap / Longevity List) Lyssna Lyssna igen Fortsätt Lyssnar... Lyssna senare Lyssna senare #016: Sebastian Brunemeier (ex Apollo Health Ventures, co-founder Cambrian Biopharma) - June 10th, 2021 10 jun 2021 · The Longevity Biotech Show Lyssna senare Lyssna senar … ne of the masterminds behind VitaDAO, a decentralized organization that aims to fund and commercialize longevity research -- all on the Ethereum blockchain. Lyssna Lyssna igen Fortsätt Lyssnar... Lyssna senare Lyssna senare #013: Marco Quarta (Rubedo Life Sciences) - May 20th, 2021 21 maj 2021 · The Longevity Biotech Show Lyssna senare Lyssna senare Markera som spelad Betygsätt Ladda ned Gå till podcast Dela Marco Quarta is a co-founder and CEO of Rubed
YuvaBio – tackling wrinkles, hair loss... and fertility Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search Leal Therapeutics doses fir... AnHorn
Interview with Yuva Biosciences co-founders Keshav Singh and Greg Schmergel — Health Business Group 0 Skip to Content Services▾ Growth Strategy Due Diligence for Transactions Sectors ▾ Tech-enabled Healthcare Services Life Sciences Digital Health and AI Private Equity/Investors Case Studies About ▾ Consultants History Testimonials Podcast Press Contact Open Menu Close Menu Services▾ Growth Strategy Due Diligence for Transactions Sectors ▾ Tech-enabled Healthcare Services Life Sciences Digital Health and AI Private Equity/Investors Case Studies About ▾ Consultants History Testimonials Pod
- YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Yuva Bio raises $7.5m and partners on hair loss treatment targeting mitochondrial dysfunction Skip to content News Data Podcast Clinics News Data Podcast Clinics Search Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Advertise NEWSLETTER News Data Podcast Clinics News Data Podcast Clinics Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire Investment Biotech Research AI/Tech Supplements Clinics Ecosystem LT Wire About Contact About Contact Advertise nEWSLETTER Search Search … very was lauded as a significant advancement in hair loss by BosleyMD, which is rolling out its new ‘Revive Plus Densifying Foam’ with Y100 technology to retailers, beauty chains, pharmacy chains, and e-commerce sites. “Applying a unique platform based on mitochondrial science to create breakthrough products for skin care and hair care, as Yuva Biosciences has done, is a real game-changer, with noticeable effects being seen already in multiple clinical trials and now in produ … e funding round was led by VentureSouth, with participation from Longevity Tech Fund, TBD Angels, and Atma Capital. “Tens of billions of dollars are spent every year on cosmetics products that address symptoms of aging but don’t actually slow the aging process,” said Matt Dunbar, managing director at VentureSouth. “Yuva Biosciences’ technology solves this problem with once-in-a-generation innovation by fighting a key root cause of aging, mitochondrial dysfunction.
Yuva Biosciences, Inc. - Drug pipelines, Patents, Clinical trials - Synapse Products Data Feature Plans Request Demo Sign Up for Free Last update 08 May 2025 Yuva Biosciences, Inc. Startups | Holding Company | 2017 | Alabama, United States | 10-50 | www.yuvabio.com Startups | Holding Company | 2017 | Alabama, United States | 10-50 | www.yuvabio.com Last update 08 May 2025 Overview Pipeline Deal Translational Medicine Profit Grant & Funding(NIH) Investment Financing Overview Tags Endocrinology and Metabolic Disease Small molecule drug Disease domain score A glimpse into the focused therapeu … itions of over 360K organizations with Synapse. login or view full example data Grant & Funding(NIH) Access more than 2 million grant and funding information to elevate your research journey. login or view full example data Investment Gain insights on the latest company investments from start-ups to established corporations. login or view full example data Financing Unearth financing trends to validate and advance investment opportunities. login or view full example data
Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™ | ELAB Stock News --> STOCK TITAN Login Sign up Login Sign up 0 HOME --> NEWS FEED Stock News Live Stock News Today Trending News AI news FDA Approvals Clinical Trials Crypto News Merger & Acquisitions Earnings Offerings IPO News Stock Splits Top News - Gainers Top News - Losers SEC FILINGS SEC Filings Live SEC Filings Today Form 4 - Insider Trading 8-K - Material Events 10-K - Annual Reports 10-Q - Quarterly Rep … Holdings (NASDAQ: ORBS) Reports Total Holdings of Approxi... DLHC DLH Contract Award Opens New Growth Channels with U.S Navy RKLB NASA Selects Rocket Lab to Launch Sun, Earth Sciences Missions SHPH United Dogecoin Advances Data Centre and Power Infrastructure Str... ON onsemi to Acquire Synaptics to Enable the Next Generation of Inte... ILLR Triller Group (Nasdaq: ILLR): The Reverse Split Is Not the Story ... BMNR ORBS Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings o … Holdings (NASDAQ: ORBS) Reports Total Holdings of Approxi... DLHC DLH Contract Award Opens New Growth Channels with U.S Navy Previous Next --> Overview Financials News SEC Filings Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™ Rhea-AI Impact (High) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary English French German Italian Korean Spanish … ONS AND METHODS FOR THE TREATMENT OF SKIN, SCALP, AND HAIR IMPROVEMENT”, Patent Application Serial No 63/664,517, covers the unique and novel combination of Elevai exosomes and Y100, technologies that the inventors believe are synergistic and could allow significantly better results than either technology used alone. The second patent, “PREPARATIONS INCLUDING LIPID BILAYER NANOPARTICLES”, Patent Application Serial No 63/664,526, covers the use of exosomes (and similar lipid b … ner with a scientific innovator such as Elevai Labs to successfully combine our award winning technologies to create revolutionary new products for the world of medical aesthetics. We look forward to helping people concerned about the signs of aging through use of the Elevai S-Series Root Renewal System.” BosleyMD® has lauded the Y100 technology
UAB-Born, Birmingham-Built: YuvaBio’s Path from Discovery to Scaled Impact - Innovate Alabama Skip to Content Innovate Alabama Helping Innovators Grow Roots Show Additional Navigation Options Entrepreneurs Investors Talent Programs Choose AL Stories Connect Asset Map About Press Contact May 27, 2025 · Innovators UAB-Born, Birmingham-Built: YuvaBio’s Path from Discovery to Scaled Impact A Birmingham startup is rethinking aging from the inside out, using mitochondrial science to drive breakthroughs in healthy aging and longevity. Yuva Biosciences was born out of research at th … t-derived investments. Yuva Biosciences became one of Station 41’s first grant recipients. In 2024, the company received support from the Station 41 Therapeutics Development Fund, gaining both capital and access to flexible lab space alongside other early-stage ventures. That support allowed YuvaBio to accelerate its work on ovarian aging and scale its operations without leaving the state. “Southern Research’s Station 41 Therapeutic Development Fund has bee … dvanced Manufacturing Footprint Meet the Founder: Innovate Alabama Supplemental Grant Recipients Meet the Founder: Innovate Alabama Supplemental Grant Recipients Applied Technology Solutions Get the Download The latest stories of inspiration and innovation happening all around our state, right to your inbox. Name (Required) First Last Email (Required) Interests (Required) Access to Resources Talent Development Lifestyle & Recreation Home Entrepreneurs Investors Talent Cho … ate Alabama Network State Small Business Credit Initiative (SSBCI) Supplemental Grant Program Tax Credit Program QuantHub Alabama Data Scholars About Our Story Board of Directors Staff Press Releases Contact Email Us 1320 1st Avenue South Birmingham, AL 35233 Speaking Engagement Requests Miscellaneous Stay Inspired and Informed Get the latest stories of inspiration and innovation happening all around our state. Email FOLLOW LinkedIn X Instagram Facebook Innovate Alabama • 132
EX-10.6 10 ea022983601ex10-6_pmgchold.htm COLLABORATION AGREEMENT, DATED NOVEMBER 28, 2023, BY AND BETWEEN THE REGISTRANT AND YUVA BIOSCIENCES, INC. Exhibit 10.6 Execution Version [*]: THE IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THE AGREEMENT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED COLLABORATION & LICENSE AGREEMENT This Collaboration and License Agreement (this “ License Agreement ” or “ Agreement ”) is made and entered into as of the date of the last signature herein (the &ld … e Field (the “ Purpose ”); and WHEREAS , Yuva Bio desires to grant ELEVAI, and ELEVAI desires to accept from Yuva Bio, a license under the Licensed IP to Develop and Manufacture (each, as defined below) Licensed Products in the Field in the Licensed Territory for the sole purpose of Commercializing such Licensed Products in the Field in the Licensed Territory, and to Develop Combination Products in the Field in the Licensed Territory, all on the terms and s … sale, offer for sale, export, import of other disposition of which, but for the grant of a license, would infringe or contribute to the infringement of the Yuva Bio Patents or (ii) which incorporates Yuva Bio Technology. 1.7 “ Commercialize ”, “ Commercialization ” and “ Commercializing ” shall mean to (directly or indirectly through any third party) import, market, advertise, warehouse, distribute and sell, and educate potential cus … 1.13 “ Field ” means non-prescription skincare products for topical application that are offered or sold in Authorized Channels. 1.14 “ First Commercial Sale” means with respect to any Licensed Product in a Licensed Territory, the first sale of such Licensed Product under this Agreement. Licensed Products used in testing, Clinical Trials, or as marketing samples to develop or promote Licensed Products shall be excluded from commercial sales. &nb … sional applications, and patents corresponding to any of the foregoing that may grant or may have been granted on any of the foregoing, including reissues, re-examinations and extensions and any supplemental protection certificates, or the like; (b) all Know-How, work product, trade secrets, inventions (whether patentable or otherwise), data, pro
Exosome X Mitochondrial Technology: Elevai Labs Enters Into Licensing Agreement With Yuva Biosciences - - ModernAesthetics YoungMD Connect Subscribe Log In Create Account Back Energy-based Devices Injectables Minimally Invasive Practice Development Regenerative Medicine Skincare Surgical Weight Loss Videos/Podcasts Face Value Updates in Energy-Based Devices RF Microneedling Safety See All Columns Energy-Based Devices Perspectives Injectables Perspectives Surgical Perspectives News Energy-Based Devices Injectables Regenerative Medicine Surgical Weight Loss See All Conferences Music City SCALE O
yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us The Leader in AI-Driven Mitochondrial Health Targeting aging/aging-related diseases through ground-breaking AI & mitochondrial science. MITOCHONDRIAL HEALTH Unique MitoNova TM AI Platform MitoNova TM is an AI platform optimized for the discovery of compounds that improve mitochondrial health and trained on years of testing both in-ho … ” April 10, 2025. Yuva Biosciences Receives Prestigious Therapeutic Development Fund Grant from Southern Research to Address Ovarian Aging,July 6, 2024 “New Hair-Loss Biotechnology Has Hit the Mass Market,” American Salon, May 7, 2024. “Yuva Bio raises $7.5m and partners on hair loss treatment targeting mitochondrial dysfunction,” Longevity.Technology, February 26, 2024. “One of the Biggest Innovations in Hair Loss We’ve Seen in Twenty-Five Years” — BosleyMD® Teams With Start … ment with Yuva Biosciences,” November 29, 2023. YuvaBio won the People’s Choice Award at the Octane Aesthetics Tech Forum in Newport Beach, CA. January 26, 2023. READ ALL Our mission is to build the best AI platform to discover compounds that improve mitochondrial health for all people! Home About Us News Careers Contact Home About Us News Careers Contact Company HQ/Lab:1500 First Avenue N, Suite L133, Birmingham, AL 35203 +New York City and Boston Copyright © 2026 All rights
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
News – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us News “This Serum Actually Regrew My Thinning Postpartum Hair,” Wall Street Journal, August 22, 2025. “Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases” April 10, 2025. Yuva Biosciences Receives Prestigious Therapeutic Development Fund Gra … ment with Yuva Biosciences,” November 29, 2023. YuvaBio won the People’s Choice Award at the Octane Aesthetics Tech Forum in Newport Beach, CA. January 26, 2023. Yuva Biosciences To Present Revolutionary Technology at Octane’s Aesthetics Tech Forum, January 26, 2023. “How Dr. Keshav Singh became a pioneer of mitochondria research,” Global Indian, November 25, 2022. Dr. Keshav Singh is co-PI of a Space Biology Research Study selected by NASA, October 17, 2022. Dr. Singh publis
Partners & Products – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Partners & Products YuvaBio® Y100™ Y100™ is now available for licensing for use in a wide variety of consumer products, including skincare, haircare, and more! A clinically proven cosmetic active ingredient that boosts mitochondrial health and function, reversing visible signs of aging. Ideally suited
Yuva Biosciences Scientific Founder Publishes COVID-19 Research In The American Journal Of Physiology - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell an … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search BioMidwest Yuva Biosciences Scientific Founder Publishes COVID-19 Research In The American Journal Of Physiology August 25, 2020 | 2 min read Twitter LinkedIn Facebook Email Print Yuva Biosciences, an anti-aging startup based on technology developed by one of the world leaders in mitochondrial sciences, Dr. Keshav K. Si … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Dr. Keshav K. Singh Joins Allergan Aesthetics Science Of Aging(SM) Faculty - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opini … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Business Dr. Keshav K. Singh Joins Allergan Aesthetics Science Of Aging(SM) Faculty June 4, 2020 | 2 min read Twitter LinkedIn Facebook Email Print Yuva Biosciences, an anti-aging startup based on technology developed by one of the world leaders in mitochondrial sciences, Dr. Keshav K. Singh, is pleas … arnered national and international recognition because of its potentially broad application. Yuva Biosciences was selected as the most recent UAB Faculty Startup of the Year, as Dr. Singh is the Joy and Bill Harbert Endowed Chair and Director of Cancer Genetics at the University of Alabama at Birmingham . About Allergan At Allergan Aesthetics, an AbbVie company (NYSE: ABBV), we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthet … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Management Team – yuvabio Skip to content Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Home About Us Management Team Board of Directors Advisory Board MitoNova AI Partners & Products News Careers Contact Us Management Team Greg Schmergel Co-Founder and CEO Greg Schmergel is a serial entrepreneur who has started multiple companies, including Nantero, Inc. (one of the world’s leading nanotechnology companies), ExpertCentral.com, and Tower Group. He serves on multiple Boards including as member of the Board of Trustees … red by Reuters). Greg was a previous Ernst & Young Entrepreneur of the Year Award winner in New England, in the emerging technology category, and was also inducted into Boston Business Journal’s 40-under-40 Hall of Fame in 2018. Greg stays active in supporting the entrepreneurship and business community including being a judge in the Harvard Business School New Venture Competition and at the MassChallenge accelerator, a guest speaker at entrepreneurial classes and groups, … sition the bank into a first-time venture firm that successfully raised $50M in Fund I. During his time, Saksham helped at all levels of fund management including fundraising, deal sourcing, conducting due diligence, and reporting. After departing Boston/Cambridge to pursue entrepreneurial efforts, Saksham joined the University of Alabama at Birmingham (UAB) as a Venture Advisor in 2018. At UAB, he assisted faculty and staff in evaluating the commercial potential of their ear
New Company: Yuva Biosciences - Follicle Thought Skip to content About Articles Contact Updates Promos New Company: Yuva Biosciences Home » Hair Growth Treatment News » Hair Growth Treatment » New Company: Yuva Biosciences October 8, 2019 / 48 Comments One of the leading researchers in the field of mitochondrial science has started a company to reverse the effects of human aging, including hair loss. In July 2018, researchers at the University of Alabama, led by Keshav Singh PhD, published findings on a novel model for restoring mitochondrial function. The team found that by turning off a gene